Close



Dec 2, 2022 10:42AM
Nov 10, 2022 04:05PM
Nov 3, 2022 04:01PM
Nov 3, 2022 09:24AM
Aug 18, 2022 09:16AM
Aug 2, 2022 04:02PM
Aug 2, 2022 04:01PM Rigel Pharmaceuticals and Forma Therapeutics Announce Licensing Agreement for Olutasidenib, a Novel Mutant IDH1 Inhibitor for the Potential Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Apr 13, 2018 10:58AM
Apr 13, 2018 05:03AM
Apr 12, 2018 03:58PM
Apr 12, 2018 03:57PM
Apr 12, 2018 02:16PM
Apr 3, 2018 01:33PM
Apr 3, 2018 10:19AM Rigel Pharmaceuticals (RIGL) PT Lowered to $6 at Cantor Fitzgerald Following Phase 2 Data
Apr 2, 2018 05:40PM
Mar 7, 2018 01:47AM
Mar 6, 2018 04:01PM
Jan 4, 2018 07:30AM
Dec 8, 2017 07:32AM
Dec 8, 2017 07:30AM
Nov 7, 2017 04:01PM Rigel Announces Third Quarter 2017 Financial Results and Provides Company Update
Nov 6, 2017 07:10AM
Oct 2, 2017 09:32AM
Oct 2, 2017 07:36AM
Oct 2, 2017 07:30AM
Aug 1, 2017 04:01PM
Jun 22, 2017 04:14PM
Jun 22, 2017 04:05PM Rigel Announces Oral Presentation of TAVALISSE™ (fostamatinib disodium) Phase 3 Clinical Data at the European Hematology Association 22nd Annual Congress
Jun 19, 2017 09:31AM
Jun 19, 2017 07:31AM
Jun 19, 2017 07:30AM

12,336 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All